Real-World Dosing of Evidence-Based Medications for Heart Failure: Embracing Guideline Recommendations and Clinical Judgement

European Journal of Heart Failure - United States
doi 10.1002/ejhf.915
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Taxonomy of Reasons for Not Prescribing Guideline-Recommended Medications for Patients With Heart Failure

The American Journal of Geriatric Pharmacotherapy
2010English

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

Clinical Pharmacokinetics
Pharmacology
2015English

Chronic Heart Failure: Clinical Guidelines and Real Clinical Practice

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2016English

Real-World Clinical Diagnostics of Heart Failure Patients With Reduced or Preserved Ejection Fraction

ESC heart failure
Cardiovascular MedicineCardiology
2020English

Pcv134 - Real-World Data Sources for Heart Failure Research: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Reasons for Guideline Nonadherence at Heart Failure Discharge

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2018English

Risks and Benefits of Medications in Real-World Practice

Archives of Internal Medicine
2012English

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Outcomes of Angiotensin Receptor-Neprilysin Inhibitor Prescriptions for Patients With Heart Failure and Reduced Ejection Fraction in Real World Clinical Practice

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy